{
    "code": "52026578",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026578",
    "time": "2017-03-10 03:07:00",
    "許可證字號": "衛部藥輸字第026578號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/12\/11",
    "發證日期": "104\/12\/11",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202657807",
    "中文品名": "泰伏樂膠囊50毫克",
    "英文品名": "Tafinlar Capsules 50mg",
    "適應症": "Dabrafenib單一療法或與trametinib併用，可用於治療BRAF V600 突變陽性且無法以手術切除或轉移性的成人黑色素瘤",
    "劑型": "130膠囊劑",
    "包裝": "12-1000粒塑膠瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "DabrafenibMesylate(Micronized)"
    ],
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F130044400  GLAXO OPERATIONS UK LIMITED",
        "製造廠廠址": "PRIORY STREET, WARE, HERTFORDSHIRE, SG12 0DJ, UNITED KINGDOM.",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F410122000  GLAXO WELLCOME, S.A.",
            "製造廠廠址": "AVENIDA EXTREMADURA 3, ARANDA de DUERO, BURGOS 09400, SPAIN",
            "製造廠公司地址": "",
            "製造廠國別": "SPAIN",
            "製程": "包裝及分裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013005310",
            "成分名稱": "Dabrafenib Mesylate (Micronized)",
            "含量描述": "(eq. to Dabrafenib..….50 MG)",
            "含量": "59.2500000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020265780001-104-12-31.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026578&Seq=001&Type=9"
        },
        {
            "title": "020265780003-104-12-31.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026578&Seq=005&Type=8"
        }
    ]
}